$49.38 +0.79 (%) Merck & Co Inc - NYSE

Feb. 5, 2016 | 04:00 PM

Partner Headlines

  1. Stocks Open Down, Reverse Higher; Prestige, Nike, Fastenal Soar

    IBD | Feb. 4, 2016 | 10:50AM EST
  2. Merck & Co., Inc. Falters After Q4 Report

    Benzinga | Feb. 3, 2016 | 14:00PM EST
  3. Merck Stock Slides As Q4 Revenue, Guidance Miss Expectations

    IBD | Feb. 3, 2016 | 11:44AM EST
  4. Stocks Backtrack On Services Data; Seagate, Edwards, WebMD Jump

    IBD | Feb. 3, 2016 | 10:48AM EST
  5. Stock Futures Up As Oil Behaves; Syngenta Up On ChemChina Deal

    IBD | Feb. 3, 2016 | 09:03AM EST
  6. Polcari: Stocks Slide, KS Fed Pres Ester George Suggests Rate Hike

    IBD | Feb. 3, 2016 | 09:01AM EST
  7. Keep an Eye on These 10 Stocks for February 3, 2016

    Benzinga | Feb. 3, 2016 | 04:28AM EST
  8. Earnings: Pharma Tends to Top Street Estimate—Can PFE, MRK Repeat?

    Benzinga | Feb. 1, 2016 | 10:38AM EST
  9. Stock Marquee is Crowded in Week Ahead: Oil, Earnings, Labor Data

    Benzinga | Feb. 1, 2016 | 10:28AM EST
  10. Merck Receives FDA Approval of Hep C Drug ZEPATIER; To Cost $54,600/Patient for 12-Week Course

    Benzinga | Jan. 28, 2016 | 19:11PM EST
  11. Affimed to Collaborate with Merck to Evaluate AFM13 in Combination with KEYTRUDA for Patients with Hodgkin Lymphoma

    Benzinga | Jan. 25, 2016 | 05:02AM EST
  12. Merck

    IBD | Jan. 15, 2016 | 18:43PM EST
  13. Merck, BioLineRx teaming up

    IBD | Jan. 12, 2016 | 18:40PM EST
  14. Fast Money Traders Share Their Biotech Picks

    Benzinga | Jan. 12, 2016 | 07:14AM EST
  15. Richard Snow Makes Huge Increases in Big-Name Stocks

    GuruFocus | Jan. 8, 2016 | 14:57PM EST
  16. A Calmer Year For Pharma?

    IBD | Jan. 6, 2016 | 18:47PM EST
  17. 3 Potential Blockbuster Drugs Launching in 2016

    IBD | Jan. 6, 2016 | 09:42AM EST
  18. Washington University Initiates Clinical Study of Verastem's VS-6063 in Combination with Merck's Pembrolizumab and Gemcitabine in Pancreatic Cancer

    Benzinga | Jan. 6, 2016 | 07:53AM EST
  19. Lilly Guidance Misses Estimates On Lower Sales

    IBD | Jan. 5, 2016 | 13:18PM EST
  20. Baxalta Cuts Cancer Deal As Shire Circles Nearer

    IBD | Jan. 4, 2016 | 12:52PM EST
  21. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  22. 5 Top Stocks of the Outperforming Vanguard Health Care Fund

    GuruFocus | Dec. 24, 2015 | 15:44PM EST
  23. 5 Guru Picks in Volatile Biotech Industry

    GuruFocus | Dec. 23, 2015 | 14:24PM EST
  24. Kahn Brothers' Largest Sales During 3rd Quarter

    GuruFocus | Dec. 22, 2015 | 16:13PM EST
  25. ALK Sells European Veterinary Business to Fidelio Capital; Terms Not Disclosed

    Benzinga | Dec. 21, 2015 | 04:13AM EST
  26. Merck's KEYTRUDA Significantly Improves Survival Compared to Chemotherapy in Previously-Treated Patients with Non-Small Cell Lung Cancer Whose Tumors Express Any Level of PD-L1

    Benzinga | Dec. 19, 2015 | 11:52AM EST
  27. 4 Top Dividend Plays To Help Cure Stock Price Blues

    IBD | Dec. 17, 2015 | 17:14PM EST
  28. Biothera Announces Clinical Study to Evaluate Combination Therapy of Imprime PGG

    Benzinga | Dec. 10, 2015 | 09:00AM EST
  29. Apple, Intel, Viacom, IBM Among Best Value Stocks

    IBD | Dec. 9, 2015 | 14:27PM EST
  30. Oil Slips, Drags On Stock Futures; Keurig Soars, Chipotle Crumbles

    IBD | Dec. 7, 2015 | 09:09AM EST
  31. Must Watch Stocks for Today

    Benzinga | Dec. 7, 2015 | 04:25AM EST
  32. Benzinga's Weekend M&A Chatter

    Benzinga | Dec. 6, 2015 | 20:45PM EST
  33. Amgen, Merck target cancer

    IBD | Dec. 4, 2015 | 18:37PM EST
  34. Relypsa Stock Jumps On Buyout Rumors

    IBD | Dec. 4, 2015 | 15:31PM EST
  35. Amgen Expands Work With Merck, Files Biosimilar In EU

    IBD | Dec. 4, 2015 | 13:46PM EST
  36. Stocks Wobble After ECB Rate Vote; Avago, Dyax up

    IBD | Dec. 3, 2015 | 11:40AM EST
  37. Merck

    IBD | Dec. 1, 2015 | 18:47PM EST
  38. 3 Big Pharma Upgrades (And One Downgrade) At Barclays

    IBD | Dec. 1, 2015 | 15:31PM EST
  39. Stocks Hold Solid Gains; Boeing Leads Dow; LinkedIn Revs Up

    IBD | Dec. 1, 2015 | 11:58AM EST
  40. Stocks, Volume Open Higher; Early Risers: Boeing, Thor, Wynn

    IBD | Dec. 1, 2015 | 10:34AM EST
  41. Amazon's PT Raised; Yum, J&J, Merck, Lilly Upgraded

    IBD | Dec. 1, 2015 | 09:15AM EST
  42. Small Caps Show Early Strength; Microsoft, Merck, Fitbit Rising

    IBD | Nov. 30, 2015 | 09:09AM EST
  43. Deere Announces Factory Workforce Adjustments, 220 Employees On Indefinite Leave Starting Feb 2016

    Benzinga | Nov. 30, 2015 | 09:01AM EST
  44. MITICURE for house Dust Mite Allergic Rhinitis Now Available in Japan

    Benzinga | Nov. 25, 2015 | 20:42PM EST
  45. Biotechs Weaken, But These Names Have Bullish Charts

    IBD | Nov. 25, 2015 | 17:19PM EST
  46. Benzinga's Top Initiations

    Benzinga | Nov. 24, 2015 | 09:43AM EST
  47. Palo Alto Networks PT Hiked; Cisco Started At Buy

    IBD | Nov. 24, 2015 | 09:17AM EST
  48. Merck Announces Initial Results for KEYTRUDA with Novel Immunotherapy Combinations from Three Investigational Studies Presented at the Society for Melanoma Research International Congress

    Benzinga | Nov. 21, 2015 | 20:55PM EST
  49. Lilly and Merck Expand Immuno-oncology Collaboration with Phase III Nonsquamous Non-Small Cell Lung Cancer Trial

    Benzinga | Nov. 19, 2015 | 06:33AM EST
  50. Gilead still tops in HCV drugs

    IBD | Nov. 18, 2015 | 18:48PM EST
Trading Center